Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
2.090
-0.150 (-6.70%)
Nov 4, 2024, 4:00 PM EST - Market closed
Evogene Employees
Evogene had 142 employees as of December 31, 2023. The number of employees increased by 5 or 3.65% compared to the previous year.
Employees
142
Change (1Y)
5
Growth (1Y)
3.65%
Revenue / Employee
$66,542
Profits / Employee
-$139,908
Market Cap
11.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cosmos Health | 123 |
| Vivos Therapeutics | 123 |
| ImmunoPrecise Antibodies | 101 |
| STRATA Skin Sciences | 99 |
| BiomX | 71 |
| Biora Therapeutics | 58 |
| Apollomics | 45 |
| Sensei Biotherapeutics | 28 |
EVGN News
- 4 days ago - Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - PRNewsWire
- 6 days ago - Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - PRNewsWire
- 27 days ago - Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PRNewsWire
- 5 weeks ago - Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - PRNewsWire
- 2 months ago - Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire
- 2 months ago - Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evogene Reports Second Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule - PRNewsWire